Selenium Supplements Guide (2026): Thyroid Evidence, Dose & Safe Range

Selenium Benefits: Real in Deficiency, Risky in Excess

Looking for a tested product? See our best selenium ranked by form, dose, and cost, which also covers the safety ceiling →

Thyroid antibodies: the best-evidenced benefit, in one population

Selenium's most consistent evidence is in Hashimoto's thyroiditis. A 2024 systematic review and meta-analysis of randomized trials found that 200mcg/day of selenium (usually selenomethionine) reduced thyroid peroxidase (TPO) antibody levels in people with Hashimoto's (Huwiler 2024, PMID: 38243784). That's a real, replicated effect on a disease marker. The honest catch is the next step: a Cochrane review found insufficient evidence that lowering the antibody translates into feeling better, needing less thyroid medication, or changing the disease course. We cover the full evidence, dosing, and how to weigh that gap on our selenium for thyroid page — worth reading before starting it for this reason.

Immune function: real in deficiency, not a general booster

The strongest human evidence that selenium does something for immune function comes from a controlled trial in adults who were already running low, not from healthy, well-nourished people. Researchers gave 22 UK adults with marginal plasma selenium (below 1.2 µmol/L — about 60% of everyone they screened) either 50mcg, 100mcg, or a placebo daily for 15 weeks, then challenged them with a live attenuated polio vaccine. The supplemented groups showed increased glutathione peroxidase activity, a stronger cellular immune response (more interferon gamma, an earlier peak in T-cell proliferation, more T-helper cells), and cleared the poliovirus faster with fewer viral mutations recovered from stool samples than the placebo group (Broome 2004, PMID: 15213043).

Two things matter about that result. First, every subject started out with a measurable shortfall — this was correcting a documented "functional selenium deficit," not boosting an already-adequate immune system. Second, the researchers noted that even their higher 100mcg/day dose might not have been enough to fully restore optimal function, which argues against reading this as "more selenium, stronger immunity" in general. It's a single trial (n=22), not a large meta-analysis, so treat it as good mechanistic-plus-human evidence for one specific scenario — marginal status — rather than a blanket immune-boosting claim.

The other side: what happens when you supplement without a deficiency

This is where selenium's evidence turns from encouraging to cautionary, and it's the part most "selenium benefits" content leaves out. The definitive trial for cancer prevention, SELECT, randomized 35,533 relatively healthy men to selenium (200mcg/day as L-selenomethionine), vitamin E, both, or placebo, and found no reduction in prostate cancer risk from selenium (Lippman 2009, PMID: 19066370).

A separate randomized trial found the same baseline-dependent pattern for a different outcome. In 1,202 adults without diabetes at the start, 200mcg/day of selenium (versus placebo) over an average 7.7 years of follow-up raised the overall risk of developing type 2 diabetes (hazard ratio 1.55, 95% CI 1.03–2.33). But the effect wasn't evenly distributed: risk rose specifically with baseline plasma selenium, and those in the highest baseline tertile had more than double the risk (hazard ratio 2.70, 95% CI 1.30–5.61) (Stranges 2007, PMID: 17620655). Two separate trials, two different outcomes, the same shape: the people harmed were the ones who didn't need the supplement in the first place.

The therapeutic window, and why "more" isn't the goal

A widely cited review of selenium and human health summarizes why the benefit and harm data above aren't a contradiction: supplementation confers benefit only if intake of the nutrient is inadequate to start with, and supplementing people who already have adequate intake with additional selenium may increase their risk of type 2 diabetes (Rayman 2012, PMID: 22381456). That's a U-shaped relationship, not a "more is better" one — both too little and too much carry real risk, and the zone in between is narrow. The RDA for adults is 55mcg/day; the tolerable upper limit is 400mcg/day from all sources combined, one of the tighter safe ranges of any nutrient.

Form matters too: selenomethionine (the form used in SELECT, Huwiler 2024, and most positive trials) is well absorbed, while inorganic forms like sodium selenite are absorbed somewhat less efficiently. And food sources can move the needle more than people expect — Brazil nuts in particular vary enormously in selenium content by growing region, which makes "eat a few nuts instead" a real option but not a precise one. We built a total-intake calculator that adds up supplements, multivitamins, and Brazil nuts against the 400mcg ceiling on our dosage guide — that's the page to check before stacking sources.

Selenium benefits at a glance